Article

jdsupra.com on 2017-09-02 05:01

President Trump Signs FDA User Fee Reauthorization Bill into Law – A Relief for the Medical Device Industry

On August 18, 2017, in the nick of time, President Trump signed the FDA User Fee Reauthorization Bill of 2017 (FDARA) (H.R. 2430) into law, bringing a ...

Spalding

Related news

FDA Reaches Agreement with Industry for Reauthorization of Medical Device User Fees jdsupra.com
User Fee Reauthorization Bill Includes Legislation Proposed to Improve Medical Device Regulation jdsupra.com
FDA Reauthorization Act Aims to Speed Product Reviews Through User Fee Funding jdsupra.com
Blog: User Fee Reauthorization Picks Up Steam jdsupra.com
Continuing Appropriations Act Includes FDA Reauthorization of User Fees jdsupra.com
FDA Identifies Fifteen Hospitals with Failures to Comply with User Facility Requirements for Medical Device Reporting jdsupra.com
Spalding , United States
FDA User Fee Reauthorization Legislation Enacted by Congress jdsupra.com
Phase 1 , United States , Cures
There'll Be Some Changes Made: President Signs Prescription Drug and Biologic User Fee Reauthorization Act jdsupra.com
FDA Announces Biosimilar User Fee Rates for FY 2017 jdsupra.com
House Passes FDA Reauthorization Act; Would Reauthorize Key User Fee Programs and Lengthen Medical Device Malfunction Reporting Period for Certain Products jdsupra.com
Manage
Congressional Committees Advance Bipartisan FDA User Fee Agreements jdsupra.com
FDA Announces Biosimilar User Fee Rates For FY 2020 jdsupra.com
California , United States , Switzerland
FDA User Fee Reauthorization Gains Momentum with Senate HELP Committee Approval jdsupra.com
United Kingdom , Canada , United States
FDA Establishes – And HHS Immediately Withdraws – New OTC Drug User Fee Rates jdsupra.com
Reg , Spalding , New Year , United States
FDA Announces New Device User Fees with Significant Increases for Some Submissions jdsupra.com
FDA Releases Biosimilar User Fee Act Rates for Fiscal Year 2022 jdsupra.com
FDA Releases Biosimilar User Fee Act Rates for Fiscal Year 2023 jdsupra.com
FDA Announces Upcoming Public Meeting on Its Recommendations for Reauthorizing the Biosimilar User Fee Act jdsupra.com
Silver Spring , New Hampshire
FDA User Fee Legislation Moves Forward in Senate with Multiple Policy Riders On-Board jdsupra.com
New FDA User Fee Bill Contains Rider ‎That Would Permanently Alter FDA’s Regulation ‎of Cosmetics jdsupra.com